Take Action
Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Backgrounder
Biosimilars Bulletin
Blog
Council Resource
Event
Handbook
Infographic
Issue Brief
Media
Member Spotlight
Partner Resource
Policy Recommendation
Press Release
Report
Statement
Video
Whitepapers

In the News

AAM Statement in Response to Federal Trade Commission Request for Information on PBM Business Practices
May 23, 2022
Association for Accessible Medicines Names Craig Burton as Senior Vice President, Policy & Strategic Alliances, and Executive Director of the Biosimilars Council
May 16, 2022
Biosimilars Council Encourages Stakeholders, Advocates to Join #GlobalBiosimilarsWeek
October 31, 2021
Biosimilar Medicines Produce Billions in Savings in U.S., Dramatically Reduce Oncology Spending Growth: Report
September 21, 2021
The White House - Washington DC, United States
The Biosimilars Council Applauds President Biden for Signing the Advancing Education on Biosimilars Act of 2021
April 26, 2021
The Advancing Education on Biosimilars Act of 2021 authorizes the Food and Drug Administration to educate consumers and health care providers on the benefits of biosimilar medications.
Doctor meets with diabetic senior woman at medical appointment
The Biosimilars Council Applauds Reintroduction of the Bipartisan BIOSIM Act
April 23, 2021
The Biosimilars Council strongly supports the reintroduction, and encourages swift passage, of the bipartisan BIOSIM Act (HR 2815).

Filter by Keyword

Filter by Audience

Filter by Category

Filter by Keyword

Filter by Issue

Filter by Category

Recent Tweets

Biosimilars CouncilFollow2,46510,196

Biosimilars Council advocates for policies that support patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/73dlNwCdqQ…

Biosimilars Council
Retweet on TwitterBiosimilars Council Retweeted
CSimmon_DC avatarChristine Simmon@CSimmon_DC·
7h 1528843037249613825

The @BiosimsCouncil's comment to the @FTC today outlines harmful Pharmacy Benefit Manager practices: https://bit.ly/3LMvXqE

#Biosimilars are lower cost options, but too often PBMs do not encourage their use.

Twitter feed video.
Image for the Tweet beginning: The @BiosimsCouncil's comment to the
Reply on Twitter 1528843037249613825Retweet on Twitter 15288430372496138251Like on Twitter 1528843037249613825Twitter 1528843037249613825
Load More...